CIB2 Regulates mTORC1 in Photoreceptor Autophagy
Researchers studying the pathology of age-related macular degeneration
(AMD) are looking into two proteins that play a role in photoreceptor
autophagy, a process that is essential for proper light detection.
Without this clean up by support cells, the undigested photoreceptor
material accumulates over time, contributing to a toxic environment that
eventually leads to retinal degeneration and potential vision loss. One
protein called calcium and integrin binding protein 2 (CIB2) seems to
be responsible for this photoreceptor maintenance; eyes of mice
engineered without the CIB2 gene exhibited sub-retinal pigment
epithelium (RPE) deposits, marked accumulation of
drusen markers, reduced lysosomal capacity and autophagic clearance, and
impaired
visual function. The researchers also investigated the role of a protein
called mTORC1. Involved in other human diseases such as cancer,
obesity, and epilepsy, mTORC1 plays a regulatory role in processes such
as cleaning up cellular debris. They found that mTORC1 was overactive in
mice with CIB2 mutation and also overactive in human eye tissue samples
from people with dry AMD. The mTOR protein comes in two varieties:
mTORC1 and mTORC2. Because mTOR is involved in many other cellular
processes, tinkering with it leads to major side effects. The
researchers think regulating mTORC1 via CIB2 can bypass many of these
adverse effects. One of the authors says, “Using the evolving
understanding of the mechanistic role of mTORC1, this study has provided
great insights into new ways that researchers can begin to find ways to
preserve, to treat, and/or improve macular degeneration, and thus
improve the quality of life and independent living in many older
adults.”
Selective Threshold Modulation by Inhibitory Neurons Increases Information Transmission
Researchers at the Salk Institute explored modulation of neuronal
thresholds via inhibitory neurons, testing their theory with cells in
the retina. Although ubiquitous in the brain, threshold modulation also
reduces the strength of the original signal, prompting the question as
to why such a dampening effect is so widespread. The researchers found
that the decrease in information transmission can be nearly completely
eliminated if modulation by inhibitory neurons is
applied selectively to the most sparsely responding neurons (i.e.,
neurons with the lowest spike rate) in a circuit or group of neurons.
The authors provide a mathematical (but intuitive) explanation for this
outcome relating to the curve of the information function of a single
neuron with respect to its threshold. As they explain in the paper,
"This function is concave for small thresholds and convex for large
thresholds. This is important because concave functions decrease their
value upon averaging of their inputs, as occurs as a result of threshold
modulation, while convex functions increase their value. This means
that neurons with small thresholds, i.e., high spike rates, will suffer a
decrease in information transmission upon modulation. In contrast,
neurons with large thresholds, i.e., small spike rates, will increase
information transmission upon threshold modulation." Therefore, neurons
with the smallest spike rates will experience the greatest increase in
information transmission upon threshold modulation. The researchers
tested their predictions on retinal (sustained Off-type) amacrine cells
modulating pairs of ganglion cells, termed "adapting" and "sensitizing,"
with "the main differences between these cell types are that adapting
cells
have higher thresholds and larger noise levels than sensitizing cells."
They found that the amacrine cells exert a stronger effect on the
threshold of adapting ganglion cells than on the threshold of
sensitizing ganglion cells. The exploratory techniques involve
intracellular current injection of the neurons, which is far from
clinical applications. Nonetheless, these findings at the cellular level
are relevant in providing knowledge in foundational science that could
inform later clinical
treatments.
U.K. Research Project Aims to Validate the OHTS-EGPS Glaucoma Risk Calculator
A research team in the U.K. will begin a two-year project launched in
June 2021 to improve upon ways to monitor ocular hypertension (elevated
intraocular pressure) as a risk factor for developing glaucoma, which
could lead to vision loss if not detected and treated early. Eye
pressure is considered high if it is above 21 mmHg, although there is
debate as to whether and how to treat individuals with eye pressures in
the low and mid-20s. Benefit from treatment with pressure-lowering eye
drops are weighed against adverse effects, cost, and inconvenience given
a lifetime commitment to daily use of medications. An alternative
first-line therapy is selective laser trabeculoplasty (SLT), although
this option is not effective on all patients. Thus, having a tool to
assess risk of progression from ocular hypertension to glaucoma, which
is defined by irreversible damage to the optic nerve (and other ocular
structures), would support decision-making for both clinicians and
patients. A glaucoma risk calculator called OHTS-EGPS is available that
makes use of data from the Ocular Hypertension Treatment Study and the
European Glaucoma Prevention Study clinical trials. However, the U.K.
researchers state that this risk calculator has not been tested on U.K.
patients. Their project aims to validate the OHTS-EGPS for use within
the U.K. health care system through review of anonymised NHS electronic
medical records of over 23,000 people who have ocular hypertension. More
specific goals of the project include investigating the value of
treatment in people with ocular hypertension of 22 or 23 mmHg and
validating the tool for different follow-up intervals of patients
according to their glaucoma risk. Ultimately, the project seeks to "both
optimise the management of people with ocular hypertension and reduce
costs related to the management of the condition."
Visual Backward Masking in Young Infants
Visual perception begins in the retina and is serially processed in
increasingly higher levels of the visual cortex in a bottom-up manner.
However, top-down feedback is also sent from higher to lower visual
areas. Researchers in Japan interested in the interference of this
feedback processing in the brain studied visual backward masking in
infants ages 3 to 8 months. Visual backward masking occurs when the
perception of a second object masks the perception of an immediately
preceding object. This phenomenon occurs even if the second object does
not
spatially overlap the first object, such as a contour or four dots
surrounding the object in the present experiments. To test visual
perception in infants, the researchers presented them with images of
faces on a computer screen and measured the time they spent looking at
the images, taking into account that infants look longer at faces
(compared to other images). The faces were presented in two conditions:
followed by a mask image and followed by nothing. They discovered that
infants ages 7 to 8 months, similar to adults, could not see the faces
if followed by a mask image, indicating that backward masking had
occurred. In contrast, infants ages 3 to 6 months could perceive the
faces even if they were followed by the mask. This indicates that visual
backward masking did not occur, suggesting that feedback processing is
immature in the brains of infants younger than 7 months of age. The
study's first author explains, "[Y]ounger infants do not have feedback
processing that backward
masking should interfere, and thus, masking is ineffective for them." In
the latter half of their first year of life, top-down processing begins
to take effect to provide that feedback, which becomes important in
robustly perceiving ambiguous visual input. As another author proffers,
"In return for susceptibility to visual masking, we acquire the ability
to robustly perceive ambiguous visual scenes."
Small Study Investigated the Effect of Pure Cocoa Ingestion on Photopic Visual Acuity
Researchers in Spain explored the effect of two dietary
polyphenols—cocoa flavanols and red berry anthocyanins—on visual acuity
and cone-mediated dark adaptation in healthy eyes. The study involved 37
healthy volunteers who drank a glass of milk with 2.5 grams of pure
cocoa, 10 grams of freeze-dried berry powder, or just milk (control) on
three separate visits. Interestingly, this study explored the effect of
these polyphenols in acute doses, as compared to longer term dietary
routines. Levels of polyphenols in their urine were measured after three
hours. Visual acuity was tested in both photopic ("daylight") and
mesopic (low light) conditions. Tests of dark adaptation were also
performed. Results of the study showed improvement in photopic visual
acuity in the group that ingested pure cocoa. This effect was not seen
in mesopic conditions with either cocoa or red berry ingestion, and the
trend toward improvement in photopic conditions with red berry ingestion
was not statistically significant. The investigators hypothesized that
the flavanols and theobromine, both alkaloids that stimulate the central
nervous system and found in cocoa, increase visual acuity by improving
attention or processing of visual information. The authors emphasized
that questionnaires and eye examinations were
conducted to demonstrate the absence of dietary factors or prior
pathology that could influence the analysis of results. However, they
also acknowledged that the effect of caffeine, which is also present in
pure cocoa, is unknown and could also contribute to the results.
Overall, studies into diet potentially have many confounding variables,
and a small sample size limits how far results can be extrapolated. The
authors conclude, "This work highlights the need for new research that
delves deeper into the effect of flavanols, anthocyanins and
methylxanthines on visual acuity and attention, both in acute and
chronic interventions."
In Other News
(1) Children prioritize hearing over vision given emotionally incongruent input
(2) Art: Sculptural installation explores color and light
(3) Time compression in virtual reality (Related)
Sunday, July 18, 2021
Week in Review: Number 22
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment